iSelect Fund
  • Portfolio
  • Team
    • Team
    • Selection Committee
    • Portfolio Company CEOs
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Content
    • Blog
    • Agrifood Conversations
    • FAQ
  • Contact
    • Log In
    • Register
    • My iSelect
Select Page

Vestaron Announces Series B-1 Financing

Read more

RTP agtech tackling bee-friendly pesticides raises $18M, eyes global product push

Read more

SPEAR®: Organic Biological Peptides for Eco-Friendly Crop Protection

Read more

Awarding ‘Green Chemistry’

Read more

SPEAR® Bioinsecticide Recognized with Prestigious EPA Green Challenge Chemistry Award

Read more

Study Calls for Increased Investment in Biologicals in Agriculture

Read more
« Older Entries

Related Posts

  • changes in Agriculture
    iSelect and Agriculture: Why We’re Investing
  • agriculture issues today
    10+ Questions Facing Agriculture and Where to Find the Answers
  • agrifood
    Agrifood Conversations, a New Agriculture Innovation Webinar Series
  • changes in Agriculture
    Benson Hill Biosystems and the Changing Face of Agriculture Technology
  • Microsoft
    Microsoft is Coming for Agriculture. Is That a Good Thing?

Our Networks

Food & Agriculture
Healthcare

(314) 219-8688

1401 S. Brentwood Blvd.
Suite 300
St. Louis, MO 63144

Crunchbase   Medium   Twitter   LinkedIn   Facebook   YouTube

This site is operated by iSelect Fund Management, LLC ("iSelect"), which is not a registered broker-dealer. This site includes information with respect to Portfolio Companies invested in by funds managed by iSelect. Unless specifically noted to the contrary, all Portfolio Company information included on this site is provided by the applicable Portfolio Company. Neither iSelect nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information supplied by the issuer on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

All securities-related activity is conducted by North Capital Private Securities, member FINRA/SIPC ("North Capital"). North Capital does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform. Investments in private offerings are speculative, illiquid and involve a high degree of risk and those investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results. Securities are offered through North Capital Private Securities, member FINRA/SIPC. All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.

iSelect refers to iSelect Fund Management, LLC and its affiliates, located at 1401 S. Brentwood Blvd. Suite 300, St. Louis, MO 63144 which is independently owned and operated from North Capital.

©2020 iSelect Fund
×

Consideration

With 2021 well underway and with public markets still strong, we think it is an important time to highlight some of the key private market, venture investment themes that iSelect fund has identified for the year. We believe technologies transforming the Agriculture, Food and Wellness markets will flourish, with a focus on four areas: technologies that enable better food choices to drive better health outcomes, technologies that drive better, more profitable farm operations, technologies that drive the Consumerization of Healthcare, and biome-based treatment technologies. At iSelect, we invest for impact AND performance. We offer qualified investors access to emerging growth companies through our national venture capital strategy. Our unique structure allows our investors to continue to invest in these companies as they develop.

×

Timing

Why is now the right time for venture? The answer is that now is not explicitly the right time. Venture is something we need in our economy at all times. Now is not better than any other particular time. The question is, why ever stop? When we look at the challenges we’re facing in food and healthcare the reality is there is someone, somewhere who has an insight about how to build a product that will solve those problems. And if they put the right resources to it, they will succeed. As long as we need new technology to make life better or make our lives more enjoyable, we need venture capital to help fuel those entrepreneurs.

×

What is iSelect as a product?

iSelect is a very unique product, but when you break it into its parts it’s fairly easy to understand. On the front end we’re a traditional venture capital fund. We have a diligence process. We have an investment process. We have categories of industries where we have focus and real expertise, and we invest in companies in those areas that meet requirements for the fund. On the back end we’re unique in that we don’t raise a large amount of capital at one time and deploy it over the life of our fund. Each deal that we bring onto the fund, our investors have to prove and determine to invest in that deal. We have to constantly prove our diligence standards. It’s accessible, transparent and easy for investors to come in and see our comprehensive process.

×

What is the ideal iSelect company?

We are looking for founders that are passionate and we want the problem they’re trying to solve to be big, real, and painful. We want the solution to be revolutionary and we want our capital to be able to help them solve that problem. We want to know that they have customers involved and that the solution they’ve come up with actually meets those customers’ and market needs. And we want the team to be capital efficient with the money they’re spending.

×

What does the ideal iSelect company look like?

We’re looking for a company that has an opportunity to have a 10x return to our investment or greater in a period of three to seven years. What excites us at iSelect are companies that are solving big problems. We want companies that are going to be the Monsantos of the future. Not just in the size and the scope, but the impact they have on people’s lives. We want to create positive impacts on people’s lives, so we invest in areas like agricultural production and areas like producing healthy foods for our kids. They are problems that impact real people’s lives on a daily basis. That’s what we’re trying to do at iSelect. We’re trying to solve the big problems out there. Find ways to bring capital to the entrepreneurs who are the real heroes out there getting up every morning, beating away at these things that are problems that you and me and everyone else faces in their everyday lives.

×

What is iSelect?

iSelect is a venture capital firm. What that means is we look at hundreds and hundreds of different companies and we apply tough diligence standards to each of them, looking at whether the team has a good plan for growing the business, whether the team is qualified and credible, and more. We do that to resolve the few who provide the best opportunities for investors. And then iSelect takes that smaller set of investments and goes to investors who are interested in venture capital and provides a way for them to invest in these companies, either individually or all at once. We co-invest alongside other venture capitalists. We source transactions through to an exit where the company would become public or get bought. And we manage that whole investment process on behalf of our investors.